Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03522896
Other study ID # MEEC15-044b
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 30, 2017
Est. completion date June 27, 2018

Study information

Verified date June 2018
Source University of Leeds
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Orange juice naturally contains high concentrations of hesperidin, which affects glucose absorption in in vitro experiments. This study is to test if hesperidin and other components of orange juice (not other sugars or organic acids) affect the post-prandial blood glucose concentration derived from sugars already present in the orange juice.


Description:

Healthy volunteers will consume orange juice with added water or food-grade hesperidin.


Recruitment information / eligibility

Status Completed
Enrollment 10
Est. completion date June 27, 2018
Est. primary completion date June 27, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- fasting blood glucose below 5.9 mM

Exclusion Criteria:

- fasting glucose above 6 mM pregnant

Study Design


Related Conditions & MeSH terms


Intervention

Other:
control
balancing sugars and organic acids
test meal 1
orange juice plus hesperidin low dose
test meal 2
orange juice plus hesperidin higher dose
test meal 3
diluted orange juice plus hesperidin low dose

Locations

Country Name City State
United Kingdom University of Leeds Leeds

Sponsors (1)

Lead Sponsor Collaborator
University of Leeds

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Blood glucose concentration iAUC/[glucose]max 3 hours